Follow the people · Insider
Travis Alvin Thompson
Travis Alvin Thompson files insider transactions with the SEC as a chief financial officer of Bicycle Therapeutics (BCYC). We hold 6 disclosed purchases and sales filed since 6 July 2023, 2 of them in the last 90 days.
- Files forBCYC
- Disclosed buys and sells6 in all, 2 in the last 90 days
- Last disclosure7 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 July 2023 — 15 July 2026Chief Financial Officer · Bicycle Therapeutics (BCYC)46 Form 4 lines · source: SEC Form 4
Everything they disclosed
46 entries, newest first — one per disclosure report, one per Form 4 line- was granted 60,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 417 July 2026Employee Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 819 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 104 shares of Bicycle TherapeuticsSEC Form 47 July 2026Ordinary Shares · traded 6 July 2026 · filed 7 July 2026
- ▼ sold on the open market 799 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 2 April 2026 · filed 6 April 2026
- ▼ sold on the open market 102 shares of Bicycle TherapeuticsSEC Form 46 April 2026Ordinary Shares · traded 6 April 2026 · filed 6 April 2026
- was granted 58,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 44 February 2026Employee Stock Option (right to buy) · traded 3 February 2026 · filed 4 February 2026
- was granted 58,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 44 February 2026Employee Stock Option (right to buy) · traded 3 February 2026 · filed 4 February 2026
- was granted 37,500 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 1,317 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 1,115 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- was granted 75,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 75,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2026Employee Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 37,500 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 1,317 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 1,115 shares of Bicycle TherapeuticsSEC Form 46 January 2026Ordinary Shares · traded 5 January 2026 · filed 6 January 2026
- ▼ sold on the open market 221 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 2 October 2025 · filed 6 October 2025
- ▼ sold on the open market 103 shares of Bicycle TherapeuticsSEC Form 46 October 2025Ordinary Shares · traded 3 October 2025 · filed 6 October 2025
- ▼ sold on the open market 206 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 2 July 2025 · filed 7 July 2025
- ▼ sold on the open market 100 shares of Bicycle TherapeuticsSEC Form 47 July 2025Ordinary Shares · traded 3 July 2025 · filed 7 July 2025
- ▼ sold on the open market 210 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 109 shares of Bicycle TherapeuticsSEC Form 44 April 2025Ordinary Shares · traded 3 April 2025 · filed 4 April 2025
- was granted 43,500 shares of Bicycle Therapeutics (a derivative holding)SEC Form 46 January 2025Employee Stock Option (right to buy) · traded 2 January 2025 · filed 6 January 2025
- was granted 17,500 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 1,750 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 159 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 3 January 2025 · filed 6 January 2025
- ▼ sold on the open market 2,686 shares of Bicycle TherapeuticsSEC Form 46 January 2025Ordinary Shares · traded 6 January 2025 · filed 6 January 2025
- exercised options over 1,312 shares of Bicycle Therapeutics (a derivative holding)SEC Form 413 November 2024Employee Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 154 shares of Bicycle Therapeutics (a derivative holding)SEC Form 413 November 2024Employee Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 1,109 shares of Bicycle Therapeutics (a derivative holding)SEC Form 413 November 2024Employee Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 1,312 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 1,312 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- exercised options over 154 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 154 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- exercised options over 1,109 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 1,109 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 3,241 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 209 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 231 shares of Bicycle TherapeuticsSEC Form 413 November 2024Ordinary Shares · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 153 shares of Bicycle TherapeuticsSEC Form 44 October 2024Ordinary Shares · traded 3 October 2024 · filed 4 October 2024
- ▼ sold on the open market 148 shares of Bicycle TherapeuticsSEC Form 48 July 2024Ordinary Shares · traded 3 July 2024 · filed 8 July 2024
- ▼ sold on the open market 152 shares of Bicycle TherapeuticsSEC Form 45 April 2024Ordinary Shares · traded 3 April 2024 · filed 5 April 2024
- was granted 31,000 shares of Bicycle Therapeutics (a derivative holding)SEC Form 44 January 2024Employee Stock Option (right to buy) · traded 2 January 2024 · filed 4 January 2024
- was granted 16,000 shares of Bicycle TherapeuticsSEC Form 44 January 2024Ordinary Shares · traded 2 January 2024 · filed 4 January 2024
- ▼ sold on the open market 604 shares of Bicycle TherapeuticsSEC Form 44 January 2024Ordinary Shares · traded 3 January 2024 · filed 4 January 2024
- ▼ sold on the open market 54 shares of Bicycle TherapeuticsSEC Form 45 October 2023Ordinary Shares · traded 3 October 2023 · filed 5 October 2023
- ▼ sold on the open market 61 shares of Bicycle TherapeuticsSEC Form 46 July 2023Ordinary Shares · traded 3 July 2023 · filed 6 July 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.